CRISPR Therapeutics' SWOT analysis: gene-editing pioneer's stock faces pivotal year
Related Posts
Carmakers rush to ship vehicles to US ahead of new round of April tariffs
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
Tesla chair Robyn Denholm’s $180 million stock sales come under scrutiny
Tesla board chair Robyn Denholm once again finds herself in the crosshairs of controversy over her string of recent stock…
Israeli defence minister tells military to prepare for 'extended' West Bank stay
Israeli defence minister tells military to prepare for 'extended' West Bank stay